Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
GlobalData on MSN18h
SmartCella gains rights to advance cell therapy research for Parkinson’sThe company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
North County Parkinson's Support Group Fallbrook invites anyone interested to join their monthly support group meeting, every fourth Friday of the month. The next one is Friday, Feb. 28, 10 a.m. to ...
Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...
The Washington Post on MSN7d
She was diagnosed with Parkinson’s at 27. These were her warning signs.People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback